Jiwon Gye South Korea
TBD TBD
Hours | Speakers | Title |
---|---|---|
09:00 - 09:15 | Arah Margarita Ty | My clinic experience on the combination low dose isotretinoin in combination with fractional CO2 laser in the treatment of acne and acne scars Background: Isotretinoin is widely used in the treatment of moderate to severe acne all over the world. But most Doctors often delay of about 6 months, performing Fractional CO2 Laser while patient is on-going Isotretinoin treatment due to previous recommendations so as to prevent irritation and scarring. But delaying causes more psychosocial impact for most patients as they continue to suffer scars while prolonging patient’s agony.<br/><br/>Objective: The aim of this lecture is to show the effects and possible benefits of low dose Isotretinoin use in combination with Fractional CO2 Laser.<br/><br/>Method: We have reviewed the charts and responses of 32 patients (ages 18 to 45).<br/>Patients were treated with Low-dose Isotretinoin in combination with Fractional CO2 Laser with this regimen: <br/> 10 mgs/day for 1 to 2 months, then decreased dosage to every other day for another 1 to 2 months, then 1x to 2x a week for 1 month then discontinued.<br/>Patients were monitored for side effects, patient satisfaction, and their tolerance of both treatments. <br/>Patient healing and acne clearance was measured via Goodman Grading and noted in their charts and pictures. Fractional CO2 Laser settings were about 400 to 500 ms or 27 to 30 mJ. <br/>Previous studies on combination CO2 Laser and Isotretinoin were also reviewed. <br/><br/>Results: 50% of the patients did not experience any side effects.<br/>11 patients (33%) had mild dryness of the mouth, relieved by application of lip balm.<br/>3 patients (10%) had some dry skin including nails, relieved by application of lotion.<br/>2 patients (7%) had a mild increase of hair loss, relieved by decreasing the dose to 10 mgs every other day instead of 10 mgs daily. <br/>4 patients who had dry mouth had some purging in the first 2 weeks of treatment, relieved with application of clindamycin gel on the acne for 1 week and continued use of Isotretinoin to 10 mgs OD. <br/>90% of the patients said their skin has greatly improved, with remarkable acne clearance and very good scar resurfacing, especially after 3rd and 4th sessions of CO2 Laser.<br/>Under the Goodman Grading scale, all had excellent (>50%) improvement. And 97% of patients were very satisfied with the results of the CO2 Laser in combination with Isotretinoin.<br/>And for those who experienced some side effects, they were minimal and quite tolerable, and highly recommend this combination. Healing of the skin took 3 to 5 days, which was the same for those patients using the CO2 Laser alone. No PIH noted, no scarring or keloid noted.<br/><br/>Conclusion: Based on previous studies reviewed and observing the results in our patients, Isotretinoin low dose 10mgs is safe to use in Combination with Fractional CO2 Laser in the treatment of Acne and Acne Scars. Patients are very satisfied with the results and side effects are minimal and well tolerated .Healing time is unaffected in patients on isotretinoin. And in minimizing the dose and length of time of use of Isotretinoin you can maximize use of Fractional CO2 Laser for best results. |
09:15 - 09:30 | Michael H. Gold | Acne vulgaris treatments with lasers & EBD’s in 2024 Objectives: The objectives of this presentation is to demonstrate the safety and efficacy of using EBDs to treat acne vulgaris.<br/>Introduction: Acne is the most common dermatologic disorder that dermatologists see on a regular basis in our offices. Dermatologists are fortunate to have some new topical and systemic therapies which work extremely well but some patients need more, and this is where EBD’s may play a significant role. These devices work mainly by targeting the P. acnes bacteria found in the pilosebaceous gland. <br/>Methods: Clinical studies showing the efficacy of several devices will be reviewed, including the short-pulsed 1064 nm laser, the combination 589-1319 nm laser, and the intense pulsed light sources.<br/>Results and Conclusions: This presentation will show how these devices can be incorporated into one’s clinical practice in a most successful manner. |
09:30 - 09:45 | Peter Ch’ng | Long term treatment of acne vulgaris In this session we will be discussing about the long-term treatment in acne management including the latest updates on new topical and oral agents. We will also be discussing about what’s new with isotretinoin and practical tips on how to use in our daily practice. Finally I’ll talk about the latest devices used for the treatment of acne. |
09:45 - 10:00 | Hei Sung Kim | Optimizing the use of acne dermosmetics: Skincare recommendation tailored to asian patient subgroups Comming Soon |
10:00 - 10:15 | Kumiko Koromohara | Potential of using devices for japanese acne patients in addition to standard topical and oral medication Currently in Japan, acne treatment is widely carried out in accordance with the guidelines created in 2008 and has been somewhat effective.<br/>The guidelines recommend topical and oral medications, but there is also high hope for combination treatment using devices, which is not covered by medical insurance.<br/>At my clinic, I have mainly focused on treatment by devices and would like to share my experience as well as the characteristics of IPL, Fractional RF, and Gold PTT for acne treatment.<br/>Although treatment by devices is not included in the current guidelines in Japan, it can provide quick and effective results preventing post-acne scarring. In my presentation, I would like to propose how treatment by device can be combined with treatments such as topical and oral medications in the future. |
Arah Margarita Ty
Philippine Academy of Aesthetics and Age Management Medicine Inc Philippines
Curriculum Vitae
Dr Arah Margarita Papera Ty, M.D Fellow, Philippine Academy of Aesthetics and Age Management Medicine Inc (PAAAMMI) CEO, Dr A’s Beauty and Wellness Center Email: arahty@gmail.com Dr Arah Margarita Papera Ty has been conferred as a Fellow of the Philippine Academy of Aesthetics and Age Management Medicine on September 8, 2024. Dr Ty started her training in aesthetic and anti-aging medicine in 2011, locally and internationally. She started her own Aesthetic Medicine clinical practice in 2014. Her inspiration to pursue Dermatology and Aesthetics came from her mentors in San Juan De Dios Hospital, during her Internal Medicine Residency (2007 to 2010). She is currently the owner and CEO of Dr A's Beauty and Wellness Center and specializes in Laser Treatments. Dr Ty graduated from the Internal Medicine Residency Program in Manila in 2010. Dr Arah Margarita Papera Ty is a Certified Clinical Trial Investigator, and has completed several clinical trials in both pulmonology medicine and infectious disease vaccines. Further, she is a health and wellness advocate, giving lectures throughout the Philippines and abroad. Dr Ty has partnered with several life and health insurance firms in medical roles, including: Maxicare (Medical Claims Specialist), SonyLife Insurance (Medical Underwriting Doctor), Paramount Life and Filcare (Medical Director), Jardine Lloyd Thompson Insurance (Medical Director), and Biomark (Medical Director). Dr Ty's dedication to and passion for the medical profession has enabled her to handle an extensive private practice while concurrently contributing to ongoing research and the medical community.
Michael H. Gold
Gold Skin Care Center, Tennessee Clinical Research Center United States
Curriculum Vitae
Dr. Michael H. Gold is the founder and medical director of Gold Skin Care Center, Advanced Aesthetics Medical Spa, The Laser & Rejuvenation Center, and Tennessee Clinical Research Center in Nashville, TN. He is a board-certified dermatologist and dermatologic surgeon and oversees the various facets of the center's operations — a combination of medical and surgical dermatology, cosmetic dermatology, aesthetic services and research endeavors, which began in 1990. The Tennessee Clinical Research Center is regarded in the industry as one of the best clinical research centers for medical dermatology and aesthetic/cosmetic research endeavors – focusing on FDA Phase II, III, and IV clinical trials. Dr. Gold has earned worldwide recognition for providing patients with leading-edge technological advances in dermatology and aesthetic skin care. He plays an integral role in the development of new pharmaceutical products, injectable fillers and toxins, skin care, and medical devices through his clinical research practice. He presents results of his work regularly at national and international dermatology, plastic surgical, and cosmetic meetings. Dr. Gold has authored over 500 published scientific articles, 40 textbook chapters, has edited two textbooks on Photodynamic Therapy as well as been Senior Editor on textbooks on Microneedling as well as Cosmeceuticals & Skin Care. He serves on most major dermatology journal scientific boards and is the current Editor-in-Chief of the Journal of Cosmetic Dermatology and the Editor-in-Chief of Dermatological Reviews. In addition, Dr. Gold helped establish the SCALE meeting in Nashville – now entering its 18th year - it is one of the leading U.S. dermatologic and aesthetic meetings. Dr. Gold also helped start two international groups: the Dermatologic Aesthetic Surgery International League (DASIL), which aims to create a global community for the open exchange of knowledge and innovation by physicians specializing in dermatology, dermatologic surgery, and aesthetic surgery. It has become one of the most prominent and important international dermatology groups. It show cases meetings all over the world; and the 5-Continent-Congress (5CC), one of the world’s leading conferences on dermatology and aesthetic/cosmetic medicine, where he is the current President of the Congress and has overseen the growth of this meeting since its inception 13 years ago.
Peter Ch’ng
Gleneagles Kuala Lumpur and Peter Ch'ng Clinic Malaysia
Curriculum Vitae
Dr. Peter Ch’ng is a Consultant Dermatologist and Internal Medicine Specialist. He is currently the Chairperson of Cosmetic Dermatology & Laser Medicine Board of Malaysia, Vice President of Dermatological Society of Malaysia, Secretary General of Cyber Conference of Aesthetic Dermatology And Skin Surgery in APAC, Member of the Main Credentialing and Privileging Committee of Aesthetic Medical Practice and Member of Cochrane Skin Group.
Hei Sung Kim
The Catholic Unversity of Korea, Incheon ST.Mary's Hospital South Korea
Curriculum Vitae
Kumiko Koromohara
Ray Clinic Japan
Curriculum Vitae
KOMOROHARA KUMIKO DIRECTOR, OWNER of Ray Clinic Full member of Japan Society of Aesthetic Plastic Surgery Full member of The Society of Full member of Aesthetic Dermatology Full member of The American Society for Laser Medicine and Surgery Selected as development physician of Volnewmer Tokyo Medical and Dental University Hospital training Tokyo Women's Medical University professor assistant Academic presentations at numerous conferences in Japan